HDV-Interferon in the Treatment of Chronic Hepatitis C Nonresponders and Naive Hepatitis C Patients

Clinical trial NCT00703872 · UNKNOWN

Trial details

NCT number: NCT00703872
Sponsor: Hepasome Pharmaceuticals
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Hepatitis C

Start date: 2008-05-01
Primary completion: 2009-12-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.